This bill mandates that various health insurance providers, including hospital service corporations, medical service corporations, health service corporations, individual and group health insurance policies, small employer health benefits plans, health maintenance organizations, and the State Health Benefits Program, must cover medically necessary expenses for ovarian cancer screening. This coverage specifically targets symptomatic women or those at risk of ovarian cancer and includes essential diagnostic procedures such as annual pelvic examinations, ultrasounds, and blood tests for cancer markers. The benefits provided under these contracts must be equivalent to those for any other medical condition.

The bill emphasizes the importance of early detection of ovarian cancer, which is a significant health concern as it ranks as the fourth leading cause of cancer death among women in the United States. By ensuring that women at risk or showing symptoms can access necessary screening without financial barriers, the legislation aims to improve health outcomes and facilitate timely diagnosis and treatment of this serious disease. The act will take effect 180 days after its enactment and will apply to all relevant policies or contracts issued or renewed thereafter.